(Q46171594)
Statements
1 reference
Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects (English)
1 reference
B Komoroski
1 reference
N Vachharajani
1 reference
D Boulton
1 reference
D Kornhauser
1 reference
M Geraldes
1 reference
L Li
1 reference
M Pfister
1 reference
7 January 2009
1 reference
85
1 reference
5
1 reference
520-526
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference